Tumour risks and genotype–phenotype correlations associated with germline variants in succinate dehydrogenase subunit genesSDHB,SDHCandSDHD

SDHB-related pheochromocytoma and paraganglioma penetrance and genotype–phenotype correlations

(2017) Ivana Jochmanova et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures

(2017) Harry C Jubb et al.   JOURNAL OF MOLECULAR BIOLOGY

Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers

(2016) Nicola Tufton et al.   CLINICAL ENDOCRINOLOGY

Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier inSDHD-linked paragangliomas:SLC22A18andCDKN1Care candidate tumour modifiers

(2016) Attje S Hoekstra et al.   HUMAN MOLECULAR GENETICS

A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL

(2016) Isabelle Bourdeau et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma

(2016) Nelly Burnichon et al.   JOURNAL OF MEDICAL GENETICS

Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas

(2016) Rodrigo A. Toledo et al.   Nature Reviews Endocrinology

In silico functional dissection of saturation mutagenesis: Interpreting the relationship between phenotypes and changes in protein stability, interactions and activity

(2016) Douglas E. V. Pires et al.   Scientific Reports

Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion

(2015) J.A. Rijken et al.   CLINICAL GENETICS

Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer

(2015) Y. Ni et al.   ENDOCRINE-RELATED CANCER

Screening in asymptomatic SDHx mutation carriers: added value of 18F-FDG PET/CT at initial diagnosis and 1-year follow-up

(2015) C. Lepoutre-Lussey et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort

(2015) Judit Dénes et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

ClinVar: public archive of interpretations of clinically relevant variants

(2015) Melissa J. Landrum et al.   NUCLEIC ACIDS RESEARCH

Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations

(2014) Jean-Pierre Bayley et al.   BMC Medical Genetics

Phaeochromocytoma and paraganglioma: next-generation sequencing and evolving Mendelian syndromes

(2014) E. R. Maher   CLINICAL MEDICINE

Pheochromocytoma and paraganglioma syndromes: genetics and management update

(2014) M. Lefebvre et al.   Current Oncology

Oncometabolites-driven tumorigenesis: From genetics to targeted therapy

(2014) Aurélie Morin et al.   INTERNATIONAL JOURNAL OF CANCER

Phenotypic Variability and Risk of Malignancy inSDHC-Linked Paragangliomas: Lessons From Three Unrelated Cases With an Identical Germline Mutation (p.Arg133*)

(2014) Julia K. Bickmann et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline

(2014) Jacques W. M. Lenders et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Paraganglioma and phaeochromocytoma: from genetics to personalized medicine

(2014) Judith Favier et al.   Nature Reviews Endocrinology

DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach

(2014) D. E. V. Pires et al.   NUCLEIC ACIDS RESEARCH

mCSM: predicting the effects of mutations in proteins using graph-based signatures

(2013) Douglas E. V. Pires et al.   BIOINFORMATICS

A Comprehensive Next Generation Sequencing–Based Genetic Testing Strategy To Improve Diagnosis of Inherited Pheochromocytoma and Paraganglioma

(2013) Eleanor Rattenberry et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma

(2012) Mariam Jafri et al.   CLINICAL ENDOCRINOLOGY

Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High-Risk Mutations

(2012) Daniel R. Barnes et al.   GENETIC EPIDEMIOLOGY

A Decade (2001-2010) of Genetic Testing for Pheochromocytoma and Paraganglioma

(2012) A. Buffet et al.   HORMONE AND METABOLIC RESEARCH

Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome

(2012) E. Panizza et al.   HUMAN MOLECULAR GENETICS

High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands

(2011) EF Hensen et al.   CLINICAL GENETICS

Molecular Analysis of Pheochromocytoma after Maternal Transmission of SDHD Mutation Elucidates Mechanism of Parent-of-Origin Effect

(2011) Phey M. Yeap et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Low penetrance of a SDHB mutation in a large Dutch paraganglioma family

(2010) Frederik J Hes et al.   BMC Medical Genetics

Are we overestimating the penetrance of mutations in SDHB?

(2010) Francesca Schiavi et al.   HUMAN MUTATION

Research Resource: Transcriptional Profiling Reveals Different Pseudohypoxic Signatures in SDHB and VHL-Related Pheochromocytomas

(2010) Elena López-Jiménez et al.   MOLECULAR ENDOCRINOLOGY

Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations

(2010) K. A. Janeway et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patients

(2009) Jean-Pierre Bayley et al.   BMC Medical Genetics

Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out

(2009) H. P.H. Neumann et al.   CANCER RESEARCH

Penetrance and clinical consequences of a grossSDHBdeletion in a large family

(2009) DC Solis et al.   CLINICAL GENETICS

SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis

(2009) Alex Henderson et al.   Familial Cancer

Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations inSDHBandSDHD

(2009) Christopher J. Ricketts et al.   HUMAN MUTATION

Clinically Guided Genetic Screening in a Large Cohort of Italian Patients with Pheochromocytomas and/or Functional or Nonfunctional Paragangliomas

(2009) Massimo Mannelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with Paragangliomas

(2009) Nelly Burnichon et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Succinate dehydrogenase subunit B (SDHB) gene deletion associated with a composite paraganglioma/neuroblastoma

(2009) R Armstrong et al.   JOURNAL OF MEDICAL GENETICS

Denaturing High Performance Liquid Chromatography Detection of SDHB, SDHD, and VHL Germline Mutations in Pheochromocytoma

(2008) Goswin Y. Meyer-Rochow et al.   JOURNAL OF SURGICAL RESEARCH

Germline SDHB Mutations and Familial Renal Cell Carcinoma

(2008) C. Ricketts et al.   JNCI-Journal of the National Cancer Institute